Craft

Recursion Pharmaceuticals

Stock Price

$6.7

2024-10-29

Market Capitalization

$2 B

2024-10-29

Revenue

$74.7 M

FY, 2025

Recursion Pharmaceuticals Summary

Company Summary

Overview
Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology. The company uses high-throughput genetic manipulation to model diseases in multiple human cell types. 
Type
Public
Status
Active
Founded
2013
HQ
Salt Lake City, UT, US | view all locations
Website
https://www.recursion.com/
Cybersecurity rating
Sectors

Key People

  • Chris Gibson

    Chris Gibson, Co-Founder and CEO

  • Heather Kirkby

    Heather Kirkby, Chief People Officer

  • Michael Secora

    Michael Secora, Chief Financial Officer

  • Ben Mabey

    Ben Mabey, Chief Technology Officer

LocationsView all

1 location detected

  • Salt Lake City, UT HQ

    United States

    41 S Rio Grande St

Recursion Pharmaceuticals Financials

Summary Financials

Revenue (Q1, 2026)
$6.5M
Gross profit (Q1, 2026)
($6.0M)
Net income (Q1, 2026)
($117.5M)
Cash (Q1, 2026)
$654.5M
EBIT (Q1, 2026)
($128.5M)
Enterprise value
$1.4B

Footer menu